Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate

Journal of Endocrinological Investigation

Volumn 38, Issue 8, 2015, Pages 859-863

  Catalano, A ^a   Morabito, N ^a   Di Stefano, A ^a   Morini, E ^a   Basile, G ^a   Faraci, B ^a   Loddo, S ^a   Ientile, R ^a   Lasco, A ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Bone mineral density; Bone turn over; Osteoporosis; Postmenopausal; Strontium ranelate; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; CALCIUM CARBONATE; COLECALCIFEROL; CREATININE; HYDROXYPROLINE; OSTEOCALCIN; PHOSPHORUS; STRONTIUM RANELATE; BONE DENSITY CONSERVATION AGENT; THIOPHENE DERIVATIVE; VITAMIN D;

ADULT; ADVERSE OUTCOME; ARTICLE; BEDTIME DOSAGE; BONE DENSITY; BONE METABOLISM; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIETARY REFERENCE INTAKE; DRUG EFFICACY; FEMALE; FEMUR NECK; FRACTURE; HEALTH STATUS; HUMAN; HYDROXYPROLINE URINE LEVEL; LUMBAR SPINE; MAJOR CLINICAL STUDY; MIDDLE AGED; OSSIFICATION; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SPINE FRACTURE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; AGED; BLOOD; DRUG EFFECTS; OSTEOPOROSIS, POSTMENOPAUSAL; PHYSIOLOGY;

AGED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; RETROSPECTIVE STUDIES; THIOPHENES; VITAMIN D;

EID: 84937425683     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-015-0299-2     Document Type: Article

References (26)

1. Isaia G, Giorgino R, Rini GB, Bevilacqua M, Maugeri D, Adami S (2003) Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Oteoporos Int 14:577-582
2. Holick MF (2006) Resurrection of vitamin D deficiency and rickets. J Clin Invest 116:2062-2072
3. Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353-373
4. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE (2005) Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215-3224
5. Romagnoli E, Carnevale V, Biondi P, Minisola S (2014) Vitamin D supplementation: when and how? J Endocrinol Invest 37(7):603-607
6. Reid IR (2014) Effects of vitamin D supplements on bone density. J Endocrinol Invest (Epub ahead of print)
7. Cipriani C, Romagnoli E, Carnevale V, Clerico R, Pepe J, Cilli M, Diacinti D, Savoriti C, Colangelo L, Minisola S (2013) Effect of a single oral dose of 600,000 IU of cholecalciferol on muscle strength: a study in young women. J Endocrinol Invest 36(11):1051-1054
8. Adami S, Giannini S, Bianchi G, Sinigaglia L, Di Munno O, Fiore CE, Minisola S, Rossini M (2009) Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 20(2):239-244
9. Carmel AS, Shieh A, Bang H, Bockman RS (2012) The 25(OH)D level needed to maintain a favorable bisphosphonate response is 33 ng/mL. Osteoporos Int 23(10):2479-2487
10. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski J, Spector T, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459-468
11. Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90(5):2816-2822
12. Kaufman JM, Audran M, Bianchi G, Braga V, Diaz-Curiel M, Francis RM, Goemaere S, Josse R, Palacios S, Ringe JD, Felsenberg D, Boonen S (2013) Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab 98(2):592-601
13. Marie PJ, Ammann P, Boivin G, Rey C (2001) Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 69:121-129
14. Adami S, Isaia G, Luisetto G, Minisola S, Sinigaglia L, Gentilella R, Agnusdei D, Iori N, Nuti R, ICARO Study Group (2006) Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. J Bone Miner Res 21(10):1565-1570
15. Wasnich RD, Miller PD (2000) Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab 85(1):231-236
16. Bruyere O, Roux C, Badurski J, Isaia G, de Vernejoul MC, Cannata J, Ortolani S, Slosman D, Detilleux J, Reginster JY (2007) Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate. Curr Med Res Opin 23:3041-3045
17. Bruyere O, Roux C, Detilleux J, Slosman DO, Spector TD, Fardellone P, Brixen K, Devogelaer JP, Diaz-Curiel M, Albanese C, Kaufman JM, Pors-Nielsen S, Reginster JY (2007) Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab 92:3076-3081
18. Marcelli C, Chavoix C, Dargent-Molina P (2015) Beneficial effects of vitamin D on falls and fractures: is cognition rather than bone or muscle behind these benefits? Osteoporos Int 26(1):1-10
19. Poole CD, Smith JC, Davies JS (2014) The short-term impact of vitamin D-based hip fracture prevention in older adults in the United Kingdom. J Endocrinol Invest 37(9):811-817
20. Reid IR, Bolland MJ, Grey A (2014) Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383:146-155
21. Vilaca T, Camargo MB, Rocha OF, Lazaretti-Castro M (2014) Vitamin D supplementation and strontium ranelate absorption in postmenopausal women with low bone mass. Eur J Endocrinol 170(4):469-475
22. Ishtiaq S, Fogelman I, Hampson G. (2014) Treatment of post-menopausal osteoporosis: beyond bisphosphonates. J Endocrinol Invest (Epub ahead of print)
23. Peris P, Martínez-Ferrer A, Monegal A, Martínez de Osaba MJ, Muxi A, Guañabens N (2012) 25-hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis. Bone 51(1):54-55
24. Abboskhujaeva LS, Ismailov SI, Alikhanova NM (2014) Efficacy of strontium ranelate in combination with a d-hormone analog for the treatment of postmenopausal osteoporosis. Drugs R D 14(4):315-324
25. European Medicines Agency (2013) protelos-H-C-560-PSU-31: EPAR-assessment report-periodic safety update report
26. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117(4):503-511